Ironwood Pharmaceuticals, Inc. · NASDAQ:IRWD
Barclays PLC reported a 6.88% stake in Ironwood Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 12, 2025
Barclays PLC reported a 6.88% stake in Ironwood Pharmaceuticals, Inc., 11,133,857 shares, as a passive investor on Jun 30, 2025. Filed Aug 12, 2025 (Schedule 13G).
- Stake
- 6.88%
- Shares
- 11,133,857
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Barclays PLC | 6.88% | 11,133,857 |
Source
Related
- Ironwood Pharmaceuticals, Inc.
- Barclays PLC
- Ironwood Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Barclays PLC · Nov 12, 2025
- Form 4 · Denner Alexander J · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Silber Jeffrey · Jul 22, 2026